Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Dynamics of sodium channel Nav1.5 expression in astrocytes in mouse models of multiple sclerosis.
Contingent negative variation is associated with cognitive dysfunction and secondary progressive disease course in multiple sclerosis.
Effects of vitamin D on immune disorders with special regard to asthma, COPD and autoimmune diseases: a short review.
[Progressive multifocal leukoencephalopathy (review)].
Role of STIM-dependent Ca(2+) Influx in Regulatory B Cells.
Brain atrophy and lesion load in a large population of patients with multiple sclerosis.
Prediction of antibody persistency from antibody titres to natalizumab.
We are about to cure multiple sclerosis in the next 10 years, even though we do not know its cause: Yes.
The specific antigen approach in multiple sclerosis: Can it ever be enough?
Paradoxical inflammation induced by anti-TNF agents in patients with IBD.
A simple score for estimating the long-term risk of fracture in patients with multiple sclerosis.
Prolactin in multiple sclerosis.
Prevalence and Impact of Pain in Adults Aging With a Physical Disability: Comparison to a US General Population Sample.
Estimating time-varying effects for overdispersed recurrent events data with treatment switching.
Therapeutic aspects of cannabis and cannabinoids.
Fatigue and sleep disturbance in multiple sclerosis.
A clinical and radiological profile of neuromyelitis optica and spectrum disorders in an Indian cohort.
The Retrovirus/Superantigen Hypothesis of Multiple Sclerosis.
Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study.
White matter tract abnormalities are associated with cognitive dysfunction in secondary progressive multiple sclerosis.
[An update on the treatment options for multiple sclerosis].
Aquaporin water channels in the nervous system.
Multiple Sites of the Cleavage of 21- and 25-Mer Encephalytogenic Oligopeptides Corresponding to Human Myelin Basic Protein (MBP) by Specific Anti-MBP Antibodies from Patients with Systemic Lupus Erythematosus.
Autonomic dysfunction in multiple sclerosis.
The diadenosine homodinucleotide P18 improves in vitro myelination in experimental Charcot-Marie-Tooth type 1A.
Pages
« first
‹ previous
…
340
341
342
343
344
345
346
347
348
…
next ›
last »